Ambu AS's basic earnings per share (Basic EPS) for the
three
months ended in Mar. 2026 was kr0.46.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.79.
Ambu AS's EPS (Diluted) for the
three
months ended in Mar. 2026 was kr0.46.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.79.
Ambu AS's EPS without NRI for the
three
months ended in Mar. 2026 was kr0.46.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 1.79.
During the past 12 months, Ambu AS's average EPS without NRIGrowth Rate was -23.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 81.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 17.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 3.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Ambu AS's highest 3-Year average EPS without NRI Growth Rate was 81.70% per year. The lowest was -36.50% per year. And the median was 12.80% per year.
Ambu AS (OCSE:AMBU B) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Ambu AS EPS (Basic) Related Terms
Ambu AS EPS (Basic) Historical Data
* Premium members only.
The historical data trend for Ambu AS's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Ambu AS's Basic EPS for the fiscal year that ended in Sep. 2025 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (OCSE:AMBU B) has a EPS (Basic) of kr1.79 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ambu AS and its competitors.
Is Ambu AS's EPS (Basic) too high?
Ambu AS's current EPS (Basic) is kr1.79. Overall, Ambu AS has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's EPS (Basic) compare to ABT and SYK?
Ambu AS's EPS (Basic) of kr1.79 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ambu AS and its competitors. Ambu AS's current EPS (Basic) is kr1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (OCSE:AMBU B) is currently considered Significantly Undervalued. The stock's GF Value™ is kr128.17, compared to a current price of kr58.90 — trading 54% below its estimated fair value. The current EPS (Basic) is kr1.79. Ambu AS's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ambu AS (OCSE:AMBU B), the current EPS (Basic) is kr1.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (OCSE:AMBU B) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of kr58.90 is trading 54% below its estimated GF Value™ of kr128.17.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for OCSE:AMBU B:
EPS (Basic): kr1.79
GF Value™: kr128.17 vs. price of kr58.90 (54% below fair value)
No single metric tells the full story. See the OCSE:AMBU B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
92GF Score
Get the complete analysis for OCSE:AMBU B
EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:AMBU B has been successfully added to your 
